Recent research in cell replacement strategies for treating type 1 diabetes has expanded beyond auto-, allo-, and xenotransplantation to include the differentiation of induced pluripotent stem cells into insulin-producing β-cells for transplantation [6, 8, 9]. This evidence concerns the gene INS and type 1 diabetes mellitus.